Showing results (851-860 of 1,030) with videos related to

Sort By:
Pageof 103
Journal of Gastroenterology|April 30, 2010
The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn's disease independent of the IL23R genotypeMatthias Jürgens, Stephan Brand, Rüdiger P Laubender, et al.
Journal of Neuro-Oncology|May 20, 2016
Prognostic factors in recurrent glioblastoma patients treated with bevacizumabChristina Schaub, Julia Tichy, Niklas Schäfer, et al.
Journal of Applied Clinical Medical Physics|January 3, 2021
Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I/II trialYouness Nour, Christoph Pöttgen, Sied Kebir, et al.
Nuclear Medicine Communications|October 12, 2023
Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRIAleksandar Milosevic, Hanna Styczen, Johannes Haubold, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 2022
Chemotherapy and gene expression profiling in older early luminal breast cancer patients: An International Society of Geriatric Oncology systematic reviewNicolò Matteo Luca Battisti, Nienke De Glas, Enrique Soto-Perez-de-Celis, et al.
The American Journal of Gastroenterology|May 21, 2009
Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac diseaseJürgen Glas, Johannes Stallhofer, Stephan Ripke, et al.
Oncology|September 7, 2013
FLAIR-only progression in bevacizumab-treated relapsing glioblastoma does not predict short survivalChristina Schaub, Susanne Greschus, Mirko Seifert, et al.
Genes and Immunity|October 16, 2009
A 3' UTR transition within DEFB1 is associated with chronic and aggressive periodontitisA S Schaefer, G M Richter, M Nothnagel, et al.
Clinical Breast Cancer|May 24, 2016
A Prospective Comparison of Younger and Older Patients' Preferences for Adjuvant Chemotherapy and Hormonal Therapy in Early Breast CancerVictoria C Hamelinck, Esther Bastiaannet, Arwen H Pieterse, et al.
Journal of Cancer Research and Clinical Oncology|December 13, 2019
Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastomaLazaros Lazaridis, Niklas Schäfer, Sarah Teuber-Hanselmann, et al.
Pageof 103